| |
 |
|
Class Information
Number: 514/408
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) > The five-membered hetero ring consists of one nitrogen and four carbons
Description: Subject matter wherein the five-membered hetero ring consists of one nitrogen and four carbon atoms, e.g., pyrrolidine, etc.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 5712268 |
Compositions of tricyclic .beta.-lactams and uses thereof |
Jan. 27, 1998 |
| 5712151 |
Antifungal agent |
Jan. 27, 1998 |
| 5708018 |
2-aminoindans as selective dopamine D3 ligands |
Jan. 13, 1998 |
| 5705509 |
Tricyclic heterocyclic compounds as 5-HT.sub.4 receptor antagonists |
Jan. 6, 1998 |
| 5698582 |
Compositions containing taxane derivatives |
Dec. 16, 1997 |
| 5698577 |
Compositions of bicyclic .beta.-lactams and uses thereof |
Dec. 16, 1997 |
| 5696128 |
Method of regulating immune function |
Dec. 9, 1997 |
| 5693631 |
Potentiation of the microbicide 2-(thiocyanomethylthio) benzothiazole using an N-alkyl heterocyclic compound |
Dec. 2, 1997 |
| 5693674 |
Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis |
Dec. 2, 1997 |
| 5693619 |
Method of using renin inhibiting N-(2-amino-2-oxoethyl) butanediamide derivatives |
Dec. 2, 1997 |
| 5691384 |
Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis |
Nov. 25, 1997 |
| 5688813 |
Methods of inhibiting thrombin |
Nov. 18, 1997 |
| 5688812 |
Method of inhibiting seborrhea and acne |
Nov. 18, 1997 |
| 5686464 |
3,3-diphenylpropylamines, their use and preparation |
Nov. 11, 1997 |
| 5679704 |
Use of 2- (N-(2-aminoethyl)amino) acetic acid derivatives |
Oct. 21, 1997 |
| 5668136 |
Trisubstituted benzene derivatives, composition and methods of treatment |
Sep. 16, 1997 |
| 5663188 |
Synergistic therapeutic compositions of angiotensin I converting enzyme inhibitors and angiotensin II antagonists and methods |
Sep. 2, 1997 |
| 5663184 |
Methods of inhibiting CNS problems in post-menopausal women |
Sep. 2, 1997 |
| 5654312 |
Treatment of inflammatory and/or autoimmune dermatoses with thalidomide alone or in combination with other agents |
Aug. 5, 1997 |
| 5650425 |
Permanently ionic derivatives of steroid hormones and their antagonists |
Jul. 22, 1997 |
| 5646137 |
Combination treatment for osteoporosis |
Jul. 8, 1997 |
| 5646158 |
1,3,3-(trisubstituted)cyclohex-1-ene monomers and related compounds |
Jul. 8, 1997 |
| 5643915 |
Treatment of ischemia/reperfusion injury with thalidomide alone or in combination with other therapies |
Jul. 1, 1997 |
| 5624921 |
Hypotriglyceridemic aminoacetylmercapto derivatives |
Apr. 29, 1997 |
| 5622917 |
Substituted 1H--3-aryl-pyrrolidine-2,4-dione derivatives |
Apr. 22, 1997 |
| 5622987 |
5,6-dihydronaphtho [1,2-b]pyrans and their use as pharmaceutical compounds |
Apr. 22, 1997 |
| 5620971 |
Biologically active acylated amino acid derivatives |
Apr. 15, 1997 |
| 5607950 |
Muscarinic receptor antagonists |
Mar. 4, 1997 |
| 5607956 |
1-heteroazolyl-1-heterocyclyl alkane derivatives and their use and their use as neuroprotective agents |
Mar. 4, 1997 |
| 5602122 |
Method for lowering total serum cholesterol and treating hypercholesterolemia with aminoacetylmercapto derivatives |
Feb. 11, 1997 |
| 5594007 |
Method for treating spinal cord trauma with phenolic 2-piperidino-1-alkanols |
Jan. 14, 1997 |
| 5575993 |
Ionene polymers containing biologically-active anions |
Nov. 19, 1996 |
| 5576343 |
Aromatic amidine derivatives and salts thereof |
Nov. 19, 1996 |
| 5571832 |
Nitrogen-containing cyclohetero alkylamino aryl derivatives for CNS disorders |
Nov. 5, 1996 |
| 5569666 |
Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical conpositions and methods of treatment |
Oct. 29, 1996 |
| 5567411 |
Dendritic amplifier molecules having multiple terminal active groups stemming from a benzyl core group |
Oct. 22, 1996 |
| 5565460 |
Therapeutic purine agents for parkinson's disease |
Oct. 15, 1996 |
| 5559109 |
Method of treating a PAF-mediated pathology or for treating or preventing psoriasis, nephritis, asthma or shock by administering a PAF antagonist |
Sep. 24, 1996 |
| 5554641 |
Nonpeptides as tachykinin antagonists |
Sep. 10, 1996 |
| 5550134 |
Methods for inhibiting bone loss |
Aug. 27, 1996 |
| 5550148 |
PAF synthesis modulators |
Aug. 27, 1996 |
| 5550144 |
Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment |
Aug. 27, 1996 |
| 5545650 |
Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment |
Aug. 13, 1996 |
| 5543433 |
Azine-substituted phenylacetic acid derivatives and fungicides containing these |
Aug. 6, 1996 |
| 5541163 |
Renin inhibiting N-(2-amino-2-oxoethyl)butanediamide derivatives |
Jul. 30, 1996 |
| 5541207 |
Anti-neoplastic anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment |
Jul. 30, 1996 |
| 5536738 |
Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment |
Jul. 16, 1996 |
| 5536739 |
Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment |
Jul. 16, 1996 |
| 5525633 |
Triaryl-ethylene derivatives |
Jun. 11, 1996 |
| 5525347 |
Composition and methods for treating performance anxiety |
Jun. 11, 1996 |
|
|
|
